FDA briefing docs for AMGN’s Repatha panel: http://t.co/jWAaa9o1Ku http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm450071.htm